TKI | sciencenewsnet.in

Breaking News

Anatomic Lung Resection Linked to Improved Survival for Early-Stage Lung Cancer

New Study Finds Mechanical Valves Offer Superior Long-Term Survival for Aortic Valve Replacement Patients Aged 60 and Younger

Combination of dual-targeted therapies and chemotherapy shows high response rates in BRAF-mutated metastatic colorectal cancer

Blood test could guide use of anti-inflammatory drug celecoxib to reduce risk of colon cancer recurrence

Follow the Water: Searching for a Lunar Oasis

National CRNA Week: The House of Representatives Recognizes the Contributions of CRNAs

Radon: The invisible danger to homes and health

University Hospitals Now Offering Ultra-Minimally Invasive Endoscopic Spine Surgery for Patients Experiencing Back Pain

Mount Sinai International to Address Global Healthcare Leaders at the Annual Arab Health 2025 Conference and Global Medical Expo in Dubai, UAE on January 27-30

FASEB Charts Course for Responsible AI Use in Biological and Biomedical Research: Key Stakeholder Recommendations

25 Jan, 2025

NCCN Announces Selected Projects to Study Neratinib in Collaboration with Puma Biotechnology, Inc.

July 15, 2021 sarah JonasAnnouncement

The NCCN Oncology Research Program (ORP) announces projects that have been selected for funding to evaluate neratinib in various tumor types, supported by a grant from Puma Biotechnology, Inc.

NCCN Announces Research Projects Exploring Axitinib in Various Cancers, in Collaboration with Pfizer

December 15, 2020 sarah JonasAnnouncement

National Comprehensive Cancer Network Oncology Research Program announces selected studies on adding axitinib, an oral VEGF inhibitor, to treatment for melanoma, colorectal cancer, and hepatocellular carcinoma (HCC), in collaboration with Pfizer.